According to Nektar Therapeutics 's latest financial reports the company's current earnings are S$93.15 Million. In 2023 the company made an earning of -S$0.37 Billion, an increase over its 2022 earnings that were of -S$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.